Pressure BioSciences, Inc.
PBIO
Rank in Stocks
#34466
Pressure BioSciences, Inc. develops and sells high pressure technology-based... Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company’s products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formulations; BaroFold Technology platform, that is used to improve the quality and lower the production costs of protein biotherapeutics; and Pressure Cycling Technology platform which uses alternating cycles of hydrostatic pressure between ambient and ultra-high pressures to control bio-molecular interactions in sample preparation. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB440, Barocycler HUB880, and the Shredder SG3; Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, and PCT-Micro Pestle; UltraShear Mini, UltraShear K45, and UltraShear Max; and application specific kits, as well as consumable products. The company also provides pain relief, skincare solutions, personal wellness, athletic recovery, and specialized pet care products. It serves researchers at academic laboratories, government agencies, biotechnology and pharmaceutical companies, other life science institutions, and food/beverages laboratories. The company has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. Pressure BioSciences, Inc. was incorporated in 1978 and is headquartered in Canton, Massachusetts.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$10.28K
Change (1 day)
0.00%
Change (1 year)
-83.33%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Pressure BioSciences, Inc. (PBIO)
Category
Healthcare
Operating Margin for Pressure BioSciences, Inc. (PBIO)
Operating Margin as of November 2026 TTM: -480.51%
According to Pressure BioSciences, Inc.'s latest financial reports, its current operating margin (TTM) is -480.51%. At the end of 2023 the company had an operating margin of -480.51%.
Operating Margin history for Pressure BioSciences, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -480.51% | 0.00% |
| 2023 | -480.51% | 69.64% |
| 2022 | -283.25% | 35.52% |
| 2021 | -209.01% | -44.37% |
| 2020 | -375.70% | 17.13% |
| 2019 | -320.75% | 76.09% |
| 2018 | -182.15% | -12.18% |
| 2017 | -207.41% | 9.74% |
| 2016 | -189.00% | -4.70% |
| 2015 | -198.32% | -18.33% |
| 2014 | -242.83% | 9.71% |
| 2013 | -221.33% | -20.88% |
| 2012 | -279.73% | -16.02% |
| 2011 | -333.10% | 31.33% |
| 2010 | -253.63% | -1.22% |
| 2009 | -256.77% | -55.94% |
| 2008 | -582.73% | -26.88% |
| 2007 | -796.94% | -58.70% |
| 2006 | -1,929.78% | -15.82% |
| 2005 | -2,292.44% | 297.06% |
| 2004 | -577.35% | 13,172.41% |
| 2003 | -4.35% | -34.19% |
| 2002 | -6.61% | 193.78% |
| 2001 | -2.25% | -87.13% |
| 2000 | -17.48% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | -100.04% |
IE
|
|
| 10.95% | -100.02% |
CN
|
|
| 25.26% | -100.05% |
CH
|
|
| 13.54% | -100.03% |
CH
|
|
| 38.62% | -100.08% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Pressure BioSciences, Inc.'s operating margin
What is Pressure BioSciences, Inc.'s operating margin?
Pressure BioSciences, Inc.'s operating margin is -480.51%, as of Nov 2026.
What was Pressure BioSciences, Inc.'s operating margin in 2023?
In 2023, Pressure BioSciences, Inc.'s operating margin was -480.51%, compared with -283.25% in 2022.
How has Pressure BioSciences, Inc.'s operating margin changed since 2018?
From 2018 to 2023, Pressure BioSciences, Inc.'s operating margin was highest in 2018 (-182.15%) and lowest in 2023 (-480.51%).
How does Pressure BioSciences, Inc.'s operating margin compare with similar companies?
Pressure BioSciences, Inc.'s operating margin (-480.51%) is lower than that of all 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.